Страница 1 от 17 резултата
FIELD OF THE INVENTION
The present invention relates to an oligo-saccharide enhanced oat-based drink useful in treating hyperlipidaemia and hyperglycemia and improving gastrointestinal function, and to a process for preparing the same by way of tri-enzyme hydrolysis.
BACKGROUND OF THE INVENTION
Oat
FIELD OF THE INVENTION
The present invention relates to an oligo-saccharide enhanced oat-based drink useful in treating hyperlipidaemia and hyperglycemia and improving gastrointestinal function, and to a process for preparing the same by way of tri-enzyme hydrolysis.
BACKGROUND OF THE INVENTION
Oat
BACKGROUND OF INVENTION
The use of aldose reductase inhibitors (ARIs) for the treatment of diabetic complications is well known. The complications arise from elevated levels of glucose in tissues such as the nerve, kidney, retina and lens that enters the polyol pathway and is converted to sorbitol
BACKGROUND OF INVENTION
The use of aldose reductase inhibitors (ARIs) for the treatment of diabetic complications is well known. The complications arise from elevated levels of glucose in tissues such as the nerve, kidney, retina and lens that enters the polyol pathway and is converted to sorbitol
PRIORITY
The present application claims the benefit of PCT Application No. PCT/IB2015/056705 filed on Sep. 3, 2015, which further claims benefit of Indian Provisional Patent Application No. 2254/CHE/2015 filed on May 1, 2015, the entire disclosure of which is relied on for all purposes and is
FIELD
The invention relates generally to the fields of biochemistry, cell biology, molecular genetics, endocrinology, and cardiovascular medicine.
BACKGROUND
Contemporary Western type diets challenge lipid and glucose homeostasis by overloading blood with cholesterol, triglycerides, and glucose.
FIELD
The invention relates generally to the fields of biochemistry, cell biology, molecular genetics, endocrinology, and cardiovascular medicine.
BACKGROUND
Contemporary Western type diets challenge lipid and glucose homeostasis by overloading blood with cholesterol, triglycerides, and glucose.
FIELD
The invention relates generally to the fields of biochemistry, cell biology, molecular genetics, endocrinology, and cardiovascular medicine.
BACKGROUND
Contemporary Western type diets challenge lipid and glucose homeostasis by overloading blood with cholesterol, triglycerides, and glucose.
FIELD
The invention relates generally to the fields of biochemistry, cell biology, molecular genetics, endocrinology, and cardiovascular medicine.
BACKGROUND
Contemporary Western type diets challenge lipid and glucose homeostasis by overloading blood with cholesterol, triglycerides, and glucose.
PRIORITY
The present application claims the benefit of Indian Provisional Patent Application No. 1853/CHE/2012 filed on 10 May 2012 and the International Application No. PCT/IB2013/051596 filed on 28 Feb. 2013, the entire disclosure of which is relied on for all purposes and is incorporated into
FIELD OF THE INVENTION
This invention relates to methods for regulating or ameliorating lipid and glucose metabolism. This invention, further, relates to methods for reducing in a subject, a vertebrate animal (including a human), at least one of the following indices of metabolism: body fat stores,
BACKGROUND OF INVENTION
1. Field of the Invention
The present invention relates to pharmaceutical compositions, and in particular to pharmaceutical compositions containing an aldose reductase inhibitor (ARI) and an angiotensin converting enzyme (ACE) inhibitor, is useful in the prevention and
BACKGROUND
Oxidative stress and inflammation are implicated in the pathogenesis of metabolic diseases, diabetes, obesity, dyslipidemia and their associated cardiovascular complications. For example, oxidative stress is a common pathogenic factor leading to insulin resistance, beta-cell dysfunction,
FIELD OF THE INVENTION
This invention relates generally to the isolation and identification of chromones and novel chromone compositions that are effective in enhancing adiponectin production by adipocytes, and regulating genes involved in fatty acid biosynthesis, mitochondrial .beta.-oxidation of
TECHNICAL FIELD
The present invention relates to LXR.beta.-selective agonists and their use in increasing reverse cholesterol transport, elevating the plasma level of high density lipoprotein (HDL) in a mammal, and in treating metabolic disorders including, but not restricted to, cardiovascular